- Home
- CGEM vs PBT Comparison
CGEM vs PBT Comparison
Compare CGEM & PBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- PBT
- Stock Information
- Founded
- CGEM 2016
- PBT 1980
- Country
- CGEM United States
- PBT United States
- Employees
- CGEM N/A
- PBT N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- PBT Oil & Gas Production
- Sector
- CGEM Health Care
- PBT Energy
- Exchange
- CGEM Nasdaq
- PBT Nasdaq
- Market Cap
- CGEM 506.1M
- PBT 475.4M
- IPO Year
- CGEM 2021
- PBT N/A
- Fundamental
- Price
- CGEM $7.51
- PBT $9.89
- Analyst Decision
- CGEM Strong Buy
- PBT
- Analyst Count
- CGEM 8
- PBT 0
- Target Price
- CGEM $32.86
- PBT N/A
- AVG Volume (30 Days)
- CGEM 400.4K
- PBT 111.6K
- Earning Date
- CGEM 05-14-2025
- PBT 01-01-0001
- Dividend Yield
- CGEM N/A
- PBT 4.88%
- EPS Growth
- CGEM N/A
- PBT N/A
- EPS
- CGEM N/A
- PBT 0.55
- Revenue
- CGEM N/A
- PBT $27,114,144.00
- Revenue This Year
- CGEM N/A
- PBT N/A
- Revenue Next Year
- CGEM $278.37
- PBT N/A
- P/E Ratio
- CGEM N/A
- PBT $18.28
- Revenue Growth
- CGEM N/A
- PBT N/A
- 52 Week Low
- CGEM $7.30
- PBT $9.43
- 52 Week High
- CGEM $30.19
- PBT $14.26
- Technical
- Relative Strength Index (RSI)
- CGEM 31.21
- PBT 41.11
- Support Level
- CGEM $8.01
- PBT $9.90
- Resistance Level
- CGEM $9.16
- PBT $10.51
- Average True Range (ATR)
- CGEM 0.46
- PBT 0.36
- MACD
- CGEM -0.04
- PBT 0.03
- Stochastic Oscillator
- CGEM 9.62
- PBT 33.33
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.